arrow
D

David J. Feith

oncology. university of virginia school of medicine. charlottesville
H指数:31
被引数:2,864

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical Characteristics, Management, and Hematopoietic Cell Transplantation of Patients with TLR8 Gain-of-Function
2025-12-110
OAAI
Nanoromidepsin, a Polymer Nanoparticle of the HDAC Inhibitor, Improves Safety and Efficacy in Models of T-cell Lymphoma

Nanoromidepsin,一种HDAC抑制剂的聚合物纳米颗粒,在T细胞淋巴瘤模型中提高了安全性和有效性。

Blood
IF23.1
2025-09-040
PRE
Acute myeloid leukemia stratifies as 2 clinically relevantsphingolipidomic subtypes

急性髓性白血病分为2种临床相关的鞘脂组亚型

2024-02-291
OAAI
CCL22 mutations drive natural killer cell lymphoproliferative disease by deregulating microenvironmental crosstalk
2022-05-0524
OAAI